Comparison of the prognostic value of different inflammation-based scores in patients with hepatocellular carcinoma after Lenvatinib therapy

doi:10.3748/wjg.v31.i47.113776

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 47

This Article

(55)

(48)

(0)

(18)

(1)

(4036)

(2)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Dec 21, 2025; 31(47): 113776
Published online Dec 21, 2025. doi: 10.3748/wjg.v31.i47.113776

Full Size Figure Download Figure

Figure 2 Nomogram and calibration curves for predicting 1- and 2-year overall survival in hepatocellular carcinoma patients treated with Lenvatinib. A: Nomogram for predicting the probability of 1- and 2-year overall survival (OS) in hepatocellular carcinoma patients after Lenvatinib therapy; B: Calibration curve for predicting patient OS at 1 year; C: Calibration curve for predicting patient OS at 2 years. OS: Overall survival; PNI: Prognostic nutritional index.

Citation: Wu WJ, Wu ZY, Hu DD, Zhou ZG, Chen MS, Zhang YJ, Yang ZY, Chen JB. Comparison of the prognostic value of different inflammation-based scores in patients with hepatocellular carcinoma after Lenvatinib therapy. World J Gastroenterol 2025; 31(47): 113776
URL: https://www.wjgnet.com/1007-9327/full/v31/i47/113776.htm
DOI: https://dx.doi.org/10.3748/wjg.v31.i47.113776

Wu WJ, Wu ZY, Hu DD, Zhou ZG, Chen MS, Zhang YJ, Yang ZY, Chen JB. Comparison of the prognostic value of different inflammation-based scores in patients with hepatocellular carcinoma after Lenvatinib therapy. World J Gastroenterol 2025; 31(47): 113776 [PMID: 41479755 DOI: 10.3748/wjg.v31.i47.113776]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.